Electrogastrography associated with symptomatic changes after prokinetic drug treatment for functional dyspepsia  被引量:11

Electrogastrography associated with symptomatic changes after prokinetic drug treatment for functional dyspepsia

在线阅读下载全文

作  者:Hyun Chul Lim Sang In Lee Jiande DZ Chen Hyojin Park 

机构地区:[1]Department of Internal Medicine,Yonsei University College of Medicine,Seoul 120-752,South Korea [2]Division of Gastroenterology,Department of Internal Medicine,University of Texas Medical Branch,Galveston,TX 77555,United States

出  处:《World Journal of Gastroenterology》2012年第41期5948-5956,共9页世界胃肠病学杂志(英文版)

摘  要:AIM:To evaluate the effect of prokinetic drugs on electrogastrography(EGG) parameters according to symptomatic changes in patients with functional dyspepsia(FD).METHODS:Seventy-four patients with FD were prospectively enrolled in this study between December 2006 and December 2010.We surveyed the patients using a questionnaire on dyspeptic symptoms before and after an 8-wk course of prokinetic drug treatment.We also measured cutaneous pre-prandial and postprandial EGG recordings including percentage of gastric waves(normogastria,bradygastria,tachygastria),dominant frequency(DF),dominant power(DP),dominant frequency instability coefficient(DFIC),dominant power instability coefficient(DPIC),and the ratio of post-prandial to fasting in DP before and after the 8-wk course of prokinetic drug treatment.RESULTS:Fifty-two patients(70%) achieved symptomatic improvement after prokinetic drug treatment.Patients who had normal gastric slow waves showed symptom improvement group after treatment.Postprandial DF showed a downward trend in the symptom improvement group,especially in the itopride group.Post-prandial DP was increased regardless of symptom improvement,especially in the itopride group and mosapride group.Post-prandial DFIC and DPIC in the symptom improvement group were significantly increased after the treatment.The EGG power ratio was increased after treatment in the symptom improvement group(0.50 ± 0.70 vs 0.93 ± 1.77,P = 0.002),especially in the itopride and levosulpiride groups.CONCLUSION:Prokinetics could improve the symptoms of FD by regulating gastric myoelectrical activity,and EGG could be a useful tool in evaluating the effects of various prokinetics.AIM: To evaluate the effect of prokinetic drugs on elec- trogastrography (EGG) parameters according to symp- tomatic changes in patients with functional dyspepsia (FD). METHODS: Seventy-four patients with FD were pro- spectively enrolled in this study between December 2006 and December 2010. We surveyed the patients using a questionnaire on dyspeptic symptoms before and after an 8-wk course of prokinetic drug treatment. We also measured cutaneous pre-prandial and post- prandial EGG recordings including percentage of gas- tric waves (normogastria, bradygastria, tachygastria), dominant frequency (DF), dominant power (DP), domi- nant frequency instability coefficient (DFIC), dominant power instability coefficient (DPIC), and the ratio of post-prandial to fasting in DP before and after the 8-wk course of prokinetic drug treatment. RESULTS: Fifty-two patients (70%) achieved symp- tomatic improvement after prokinetic drug treatment. Patients who had normal gastric slow waves showed symptom improvement group after treatment. Post- prandial DF showed a downward trend in the symptom improvement group, especially in the itopride group. Post-prandial DP was increased regardless of symp- tom improvement, especially in the itopride group and mosapride group. Post-prandial DFIC and DPIC in the symptom improvement group were significantly in- creased after the treatment. The EGG power ratio was increased after treatment in the symptom improvement group (0.50 + 0.70 vs 0.93 + 1.77, P = 0.002), espe- cially in the itopride and levosulpiride groups. CONCLUSION: Prokinetics could improve the symp- toms of FD by regulating gastric myoelectrical activity, and EGG could be a useful tool in evaluating the effects of various prokinetics.

关 键 词:ELECTROGASTROGRAPHY Functional dyspepsia ITOPRIDE MOSAPRIDE Levosulpiride 

分 类 号:R57[医药卫生—消化系统]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象